✦ LIBER ✦

The effect of 3435C>TMDR1gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs

✍ Scribed by Marek Drozdzik; Tomasz Rudas; Andrzej Pawlik; Mateusz Kurzawski; Bogusław Czerny; Wanda Gornik; Magdalena Herczynska

Book ID: 105921414
Publisher: Springer
Year: 2006
Tongue: English
Weight: 117 KB
Volume: 62
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-006-0192-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Approaches to the treatment of early rhe

Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs

✍ Lyudmila Sizova 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Is the outcome of rheumatoid arthritis c

Is the outcome of rheumatoid arthritis changed with the use of new disease-modifying antirheumatic drugs?

✍ Kremer, Joel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

Etanercept in combination with conventio

Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate

✍ Yoshinobu Koyama; Hirokazu Shiraishi; Toshiyuki Ohta; Ayumi Uchino 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 350 KB

The importance of the disease process an

The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis

✍ Edwards, Christopher J. ;Cooper, Cyrus ;Fisher, David ;Field, Max ;van Staa, Tje 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Analysis of improvement in individual rh

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo

✍ Harold E. Paulus; Marlene J. Egger; John R. Ward; H. James Williams 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

Five-year followup of rheumatoid arthrit

Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year

✍ Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early disease‐modifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.